日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Use of open-text responses to recode categorical survey data on postpartum contraception use among women in the United States: A mixed-methods inquiry of Pregnancy Risk Assessment Monitoring System data

利用开放式文本回答对美国女性产后避孕措施使用情况的分类调查数据进行重新编码:一项基于妊娠风险评估监测系统数据的混合方法研究

Richards, Nicole K; Morley, Christopher P; Wojtowycz, Martha A; Bevec, Erin; Levandowski, Brooke A

Biomarkers of Development of Immunity and Allergic Diseases in Farming and Non-farming Lifestyle Infants: Design, Methods and 1 Year Outcomes in the "Zooming in to Old Order Mennonites" Birth Cohort Study

农业和非农业生活方式婴儿免疫和过敏性疾病发展的生物标志物:以“聚焦旧秩序门诺派”出生队列研究为例的设计、方法和1年结果

Järvinen, Kirsi M; Davis, Erin C; Bevec, Erin; Jackson, Courtney M; Pizzarello, Catherine; Catlin, Elizabeth; Klein, Miranda; Sunkara, Akhila; Diaz, Nichole; Miller, James; Martina, Camille A; Thakar, Juilee; Seppo, Antti E; Looney, R John

Graph theory enables drug repurposing--how a mathematical model can drive the discovery of hidden mechanisms of action

图论助力药物重定位——数学模型如何驱动对隐藏作用机制的发现。

Gramatica, Ruggero; Di Matteo, T; Giorgetti, Stefano; Barbiani, Massimo; Bevec, Dorian; Aste, Tomaso

New furin inhibitors based on weakly basic amidinohydrazones

基于弱碱性脒基腙的新型弗林蛋白酶抑制剂

Sielaff, Frank; Than, Manuel E; Bevec, Dorian; Lindberg, Iris; Steinmetzer, Torsten

Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA

通过干扰 CD83 mRNA 的核输出来抑制树突状细胞成熟过程中 CD83 细胞表面的表达

M Kruse, O Rosorius, F Krätzer, D Bevec, C Kuhnt, A Steinkasserer, G Schuler, J Hauber

Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L

主要组织相容性复合体II类相关p41不变链片段是溶酶体组织蛋白酶L的强效抑制剂。

Bevec, T; Stoka, V; Pungercic, G; Dolenc, I; Turk, V

Induced gene expression of the hypusine-containing protein eukaryotic initiation factor 5A in activated human T lymphocytes

活化的人类T淋巴细胞中含次黄嘌呤蛋白真核起始因子5A的诱导基因表达

Bevec, D; Klier, H; Holter, W; Tschachler, E; Valent, P; Lottspeich, F; Baumruker, T; Hauber, J

Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation

真核起始因子5A是人类免疫缺陷病毒1型Rev激活结构域介导反式激活的细胞靶点。

Ruhl, M; Himmelspach, M; Bahr, G M; Hammerschmid, F; Jaksche, H; Wolff, B; Aschauer, H; Farrington, G K; Probst, H; Bevec, D

Selection of a muramyl peptide based on its lack of activation of nuclear factor-kappa B as a potential adjuvant for AIDS vaccines

选择一种不激活核因子-κB的胞壁酰肽作为艾滋病疫苗的潜在佐剂

Schreck, R; Bevec, D; Dukor, P; Baeuerle, P A; Chedid, L; Bahr, G M